MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹15 Cr | ₹14 Cr | ₹7.26 Cr | ₹10 Cr | ₹5.78 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2023 | ₹15 Cr |
Mar2022 | ₹14 Cr |
Mar2021 | ₹7.26 Cr |
Mar2020 | ₹10 Cr |
Mar2019 | ₹5.78 Cr |
How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹15 Cr | 11.78 | |
Mar2022 | ₹14 Cr | 89.48 | |
Mar2021 | ₹7.26 Cr | -28.50 | |
Mar2020 | ₹10 Cr | 75.75 | |
Mar2019 | ₹5.78 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹7,634.2 Cr | 1% | 0.4% | 137.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | 1% |
0.4% |
137.6% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses